FastWave Medical Completes Initial Procedures In Study Of IVL System - Data Intelligence
4 Articles
4 Articles
FastWave Medical Completes Initial Procedures In Study Of IVL System - Data Intelligence
The company aims for the solution to obtain FDA approval. Credit: xmee/Shutterstock. FastWave Medical has completed the initial first-in-human procedures in the multicentre feasibility study of the Sola coronary laser intravascular lithotripsy (IVL) system. The study is designed to evaluate the performance and safety of Sola in individuals with calcified coronary artery disease. According to the company, this rupture-resistant balloon catheter a…
FastWave Medical completes initial procedures in study of IVL system
FastWave Medical has completed the initial first-in-human procedures in the multicentre feasibility study of the Sola coronary laser intravascular lithotripsy (IVL) system.The post FastWave Medical completes initial procedures in study of IVL system appeared first on Medical Device Network.
FastWave Medical announces successful 30-day first-in-human data on Sola IVL technology - Interventional News
FastWave Medical has announced the successful completion of initial first-in-human (FIH) procedures in its feasibility study of Sola, the coronary laser intravascular lithotripsy (IVL) system. The multicentre study will assess Sola’s safety and performance in patients with calcified coronary artery disease. Sola is a rupture-resistant balloon catheter designed to help physicians treat hardened calcium in blood vessels with precision and control.…
FastWave Medical announces successful 30-day first-in-human data on Sola IVL technology - Cardiovascular News
FastWave Medical has announced the successful completion of initial first-in-human (FIH) procedures in its feasibility study of Sola, the coronary laser intravascular lithotripsy (IVL) system. The multicentre study will assess Sola’s safety and performance in patients with calcified coronary artery disease. Sola is a rupture-resistant balloon catheter designed to help physicians treat hardened calcium in blood vessels with precision and control.…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage